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1684-1182/Copyright ª 2016, TaiwanAbstract Background and purpose: The phenomenon of vancomycin minimum inhibitory
concentration (MIC) creep is an increasingly serious problem in the treatment of methicillin-
resistant Staphylococcus aureus (MRSA) infections. In this study, we investigated the vancomy-
cin and daptomycin MIC values of MRSA strains isolated from pediatric patients and MRSA
colonized healthy children. Then, we assessed whether there was evidence of clonal dissem-
ination for strains with an MIC to vancomycin of  1.5 mg/mL.
Methods: We collected clinical MRSA isolates from pediatric patients and from healthy chil-
dren colonized with MRSA during 2008e2012 at a tertiary medical center in northern Taiwan
and obtained vancomycin and daptomycin MIC values using the Etest method. Pulse-field
gel electrophoresis (PFGE) and staphylococcal cassette chromosome (SCCmec) typing were
used to assess clonal dissemination for strains with an MIC to vancomycin of  1.5 mg/mL.
Results: A total 195 MRSA strains were included in this study; 87 were isolated patients with a
clinical MRSA infection, and the other 108 strains from nasally colonized healthy children.of Pediatrics, Tri-Service General Hospital, National Defense Medical Center, 325 Cheng-Kung Road,
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Microbiology, Immunology and InfectVancomycin MIC 1.5 mg/mL was seen in more clinical isolates (60/87, 69%) than colonized iso-
lates (32/108, 29.6%), p < 0.001. The PFGE typing of both strains revealed multiple pulsotypes.
Conclusion: Vancomycin MIC creeps existed in both clinical MRSA isolates and colonized MRSA
strains. Great diversity of PFGE typingwas in both strains collected. Therewas no association be-
tween the clinical and colonized MRSA isolates with vancomycin MIC creep.
Copyright ª 2016, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Staphylococcus aureus often results in serious infections,
including pneumonia, bacteremia, skin and soft tissue in-
fections, and endocarditis. These infections can occur in
hospitals, health care institutions, as well as in the com-
munity. S. aureus has the ability to colonize humans,
especially the nose.1 Colonization plays an important role
in the pathogenesis and epidemiology of infections caused
by Staphyloccocus aureus, including both methicillin-
sensitive and methicillin-resistant (MRSA).1e3 Safdar and
Bradley4 found that there is a greater risk for infection
including invasive infections following colonization with
MRSA.
Vancomycin has been a front-line drug of choice for
treating infections caused by MRSA for the past 60 years.5
Nevertheless, the association of vancomycin treatment
failures with increased vancomycin minimum inhibitory
concentration (MIC) is a recent challenge in the current
medical circumstances.6 Even when MRSA isolates are sus-
ceptible to vancomycin, treatment failure is frequently
seen. In recent years, progressive elevation in glycopeptides
MICs for S. aureus strains, a phenomenon recognized as
vancomycin MIC creep has been discussed. Investigators
have reported that an increase in vancomycin MIC for MRSA
isolates poses a substantial risk of failure. Sakoulas et al7
reported that the possibility of treatment success is lower
in patients with MRSA infections with a vancomycin MIC of
1e2 mg/mL compared with patients infected with isolates
with a vancomycin MIC 0.5 mg/mL. The Infectious Diseases
Society of America recommended that the dosage of van-
comycin should be at least 60 mg/kg/d to achieve the target
vancomycin trough level of 15e20 mg/mL for serious MRSA
infections in adults in 2009.5,8 The guideline for targeting
vancomycin trough level for pediatric patients was not dis-
cussed. As a result, we obtained more information on MRSA
treatment in children. During recent years, community-
associated (CA) MRSA infection has become increasingly
common. According to reports from Taiwan,9e11 compared
with those reported from America and other nations, CA-
MRSA isolates in Taiwan did not always contain type IV
staphylococcal cassette chromosome (SCCmec) and were
resistant to multiple non-b-lactam antibiotics, including
clindamycin and macrolides. There has been no similar study
investigating vancomycin and daptomycin MIC values of
MRSA strains in children to date.
The aim of this study was to investigate the vancomycin
and daptomycin MIC values of MRSA strains isolated from
pediatric patients and MRSA-colonized healthy childrenhang C-N, et al., An investigatio
aureus strains isolated from pedia
ion (2015), http://dx.doi.org/10.from 2008 to 2012 at a tertiary medical center using the
Etest method. If the vancomycin MIC 1.5 mg/mL, further
evaluation with pulsed-field gel electrophoresis (PFGE) and
staphylococcal cassette chromosome mec (SCCmec) ele-
ments typing were used to assess for clonal dissemination.
Methods
Study design and specimen collection
This retrospective study was conducted from 2008 to 2012
at Tri-Service General Hospital, a 1400-bed tertiary medical
center in northern Taiwan. All patients were aged  18
years and hospitalized with an MRSA infection identified
from medical records and the clinical microbiology labo-
ratory. Eligible healthy children aged  14 years without
acute medical problems were enrolled who either visited a
healthcare facility for a regular well-child checkup or
attended kindergartens in Taipei, Taiwan; this was
reviewed and approved by the National Defense Medical
Center Institutional Review Board, Taipei, Taiwan. We ob-
tained written informed consent from each child’s parents
or legal representative before nasal specimen collection or
interviews. During the 5-year study period, all children who
presented for regular health maintenance visits to our
hospital were invited to take part in this study. The kin-
dergartens were chosen based on support for the surveil-
lance investigation by the kindergartens’ principals.
The definition of CA-MRSA infection as any MRSA infec-
tion which is diagnosed in an outpatient or within 48 hours
of admission to hospital, of which the patient has none of
the following risk factors for health-care-associated MRSA:
hemodialysis; operation; residence in a long-term care fa-
cility or treatment in hospital during the previous year;
presence of a lasting catheter or percutaneous instrument
at the time of culture; or prior isolation of MRSA.12,13
Bacterial strains and antimicrobial susceptibility
testing
Nasal samples were acquired with a sterile cotton swab,
placed in transport medium (Venturi Transystem; Copan
Diagnostics, Corona, CA, USA); transported to and pro-
cessed in our microbiology laboratory within 4 hours. Cot-
ton swabs were plated on mannitol salt agar (BBL
Microbiology Systems, Becton Dickinson, Company, Sparks,
MD, USA). Distinctive morphotypes of mannitol-fermenting
colonies were selected from a mannitol salt agar plate,n of vancomycin minimum inhibitory concentration creep among
tric patients and healthy children in Northern Taiwan, Journal of
1016/j.jmii.2015.05.013
Table 1 The sources of the clinical methicillin-resistant
Staphylococcus aureus (MRSA) isolates with vancomycin
minimum inhibitory concentration  1.5 mg/mL
Sources No. of clinical MRSA isolates %
Urine 2 3.3
Wound 41 68.4
Throat 9 15
Blood 2 3.3
Sputum 4 6.7
Stool 2 3.3
Total 60 100
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plate (BBL Microbiology Systems; Becton Dickson); incu-
bated at 37C in a humidified incubator with 5% CO2. Cul-
tures on blood agar plates were screened using Slidex Staph
Plus (bioMe´rieux, Marcy l’Etoile, France). MRSA identifica-
tion and antimicrobial susceptibility testing were executed
according to Clinical Laboratory Standards Institute guide-
lines.14 All MRSA isolates were frozen at 70C for addi-
tional testing. Laboratory records of susceptibility data for
all MRSA isolates were used to define the subset of MRSA.
Duplicate isolates from the same patient were excluded.
Vancomycin and daptomycin MIC Etest
The MIC was performed using the Etest method, according
to the manufacturer’s guidelines. A suspension of saline
calibrated to the 0.5-McFarland turbidity standard was
plated onto MuellereHinton agar, onto which Etest strips
(AB BIODISK, Solna, Sweden) were applied. The plates were
incubated at 35C for 24 hours. The MIC was interpreted as
the zone of inhibition that corresponded to a concentration
gradient on the Etest strips, according to the manufac-
turer’s guidelines. Quality control was done using the
Clinical Laboratory Standards Institute-recommended
reference strain (ATCC 29213).
Genotyping
PFGE was performed using the CHEF Mapper XA system (Bio-
Rad Laboratories, Hercules, CA, USA) according to a pub-
lished protocol.10 We analyzed all findings according to
standard criteria15 and designated the pulsotypes in
alphabetical order. PFGE patterns with fewer than four
band differences from one existing pulsotype were cate-
gorized as subtypes and tagged with Arabic numbered suf-
fixes.15 In order to recognize PFGE polymorphisms, band
patterns were analyzed by Molecular Analyst Finger-
printing, Fingerprinting Plus, and Fingerprinting DST soft-
ware (Bio-Rad Laboratories). The grouping method was
done to establish a dendrogram from the matrix using the
unweighted pair group method with the arithmetic aver-
ages setting technique after estimation of similarities by
using the Pearson correlation coefficient between each pair
of organisms; the PFGE patterns were discriminated at the
80% similarity level. The chromosomal patterns were
inspected visually and the similarities of the PFGE patterns
were distributed using previously published criteria.15
SCCmec typing was performed using a multiplex polymer-
ase chain reaction strategy with sets of region-specific
primers as previously portrayed. Screening for SCCmec
was done with the primer and thermo cycler conditions
described by Boyle-Vavra et al.16
Statistical analysis
Data were entered into Microsoft Access XP software and
analysis performed using SPSS statistical software, version
10.0 (SPSS Inc., Chicago, IL, USA). The categorical param-
eters were compared using the Chi-square test, Man-
teleHaenszel test, or Fisher exact test. The data from 2008
to 2012 were combined to provide more reliable estimatesPlease cite this article in press as: Chang C-N, et al., An investigatio
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Microbiology, Immunology and Infection (2015), http://dx.doi.org/10.of the microbiological characteristics by strengthening the
power of the investigation. All parameters were initially
compared using univariate analysis; those with p < 0.05 and
those that were biologically meaningful were included in
the multivariate analysis. Nevertheless, parameters with
colinearity tested by correlation matrices were not
included in the final model at the same time. We assessed
risk factors using SAS 9.1.3 (SAS Institute, Inc., Cary, NC,
USA). All tests were two-tailed; p < 0.05 was considered
statistically significant.Results
A total of 195 MRSA strains were included in this study, of
which 87 were isolated from patients with clinical MRSA
infection. The sources of the clinical MRSA isolates are
shown as Table 1. The major source was wound culture, and
throat culture was secondary. Minor sources were stool
culture and urine culture. Other 108 strains were isolated
from nasally colonized healthy children. Among the 87
clinical isolates, 72 isolates belonged to CA-MRSA, while in
the 108 colonizing strains, 106 isolates were CA-MRSA. We
detected SCCmec gene in all CA-MRSA strains; the results
revealed that in the 87 clinical isolate group, 52 (59.8%)
strains contained type VT SCCmec, 20 (23%) strains were
SCCmec type IV. In the colonizing group, 91 (85.8%) strains
contained SCCmec type IV, and the other 15 (14.2%) strains
were SCCmec type VT.
The susceptibility test to vancomycin and daptomycin
revealed that all MRSA strains were sensitive to vancomycin
and daptomycin. The result of the MRSA-vancomycin MICs
for clinical and colonizing strains is shown in Table 2.
Among the strains with vancomycin MIC 1.5 mg/mL, more
were clinical isolates (60/87, 69.0%) than colonizing iso-
lates (32/108, 29.6%), p < 0.001. The results of the MRSA-
daptomycin MICs for the clinical and colonizing strains are
shown in Table 3. There was no significant difference be-
tween the MICs of the two groups. The distribution of
vancomycin MIC of clinical isolates is shown in Table 4.
Pulsed-field gel electrophoresis (PFGE) was performed
on 60 clinical MRSA strains and 32 colonizing MRSA isolates
with a vancomycin MIC  1.5 mg/mL. We defined similar
PFGE types by using cutoffs of 80%. A great diversity of
pulsotypes was noted among the 92 MRSA isolates subjected
to PFGE typing. Figure 1 shows the distribution of the 40
PFGE types detected among the 60 clinical MRSA strains.n of vancomycin minimum inhibitory concentration creep among
tric patients and healthy children in Northern Taiwan, Journal of
1016/j.jmii.2015.05.013
Table 2 The results of vancomycin minimum inhibitory concentration (MICs) for clinical and colonized methicillin-resistant
Staphylococcus aureus strains*
Strains No. of strains MIC50 (mg/mL) MIC90 (mg/mL) MIC < 1.5 mg/mL MIC  1.5 mg/mL Geometric mean
n (%) n (%) (mg/mL)
Clinical 87 1.5 1.5 27 (31.0) 60 (69.0) 1.39  0.41
Colonized 108 1 1.5 76 (70.4) 32 (29.6) 1.15  0.30
*p < 0.001.
MIC50Z concentration required to inhibit the growth of 50% of pathogens; MIC90Z concentration required to inhibit the growth of 90%
of pathogens.
Table 3 The results of daptomycin minimum inhibitory
concentration (MICs) for clinical and colonized methicillin-
resistant Staphylococcus aureus for clinical and colonized
strains
Strains No. of
strains
MIC50
(mg/mL)
MIC90
(mg/mL)
Geometric mean
(mg/mL)
Clinical 87 0.19 0.38 0.2  0.1
Colonized 108 0.19 0.38 0.2  0.1
MIC50Z concentration required to inhibit the growth of 50% of
pathogens; MIC90 Z concentration required to inhibit the
growth of 90% of pathogens.
Table 4 Vancomycin minimum inhibitory concentration
(MICs) of clinical isolates in 2008e2012
Year Vancomycin MIC (mg/mL) of
clinical isolates
Total MIC  1.5 (%)
0.5 0.75 1.00 1.5 2.00 3.00
2008 0 5 8 11 3 0 27 51.9
2009 1 1 0 12 4 0 18 88.9
2010 0 3 5 7 2 1 18 55.6
2011 0 0 5 15 4 0 24 79.2
2012 0 1 3 8 1 0 13 69.2
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(6.7%), PFGE type 2e5 (each had 3 subtypes respectively;
total 20%), and PFGE 6e14 (each had 2 subtypes respec-
tively; total 30%). The other PFGE types occurred sporadi-
cally. In addition, we found that the distribution of clinical
SCCmec genotypes were as follows: type II, seven isolates
(11.7%); type III, seven isolates (11.7%); type IV, 16 isolates
(26.7%); and type VT, 30 isolate (50%). Figure 2 shows the
distribution of the 21 PFGE types among the 32 colonizing
MRSA isolates. The diversity was also great. The majority
belonged to PFGE type A or its five subtypes (15.6%), PFGE
type B or its four subtypes (12.5%), and PFGE type C and D
(each has 3 subtypes; total 18.8%). The other PFGE types
were found sporadically. Besides, we noted that the dis-
tribution of colonizing SCCmec genotypes were: type II, one
isolate (3.1%); type III, one isolate (3.1%); type IV, 28 iso-
lates (87.5%); and type VT, 2 isolates (6.3%). No evidence of
clonal dissemination was noted in these populations. The
distribution and trend of vancomycin MICs over time is
shown in Figure 3. The percentage of MRSA isolates withPlease cite this article in press as: Chang C-N, et al., An investigatio
methicillin-resistant Staphylococcus aureus strains isolated from pedia
Microbiology, Immunology and Infection (2015), http://dx.doi.org/10.vancomycin MIC 1.5 mg/mL was always > 50% during the
study period of 2008e2012.Discussion
CA-MRSA was first found in Australia during the early 1990s
and rapidly spread worldwide. CA-MRSA infections in pedi-
atric patients have been increasing since 2002, and some-
where these SCCmec types are classically associated with
CA-MRSA. The majority of the MRSA strains isolated from
both pediatric patients and colonized healthy children in
Taiwan are CA-MRSA.9,10,17 In Taiwan, Tsao et al18 also
found that the prevalence rate of CA-MRSA increased
obviously during recent years (from 25.6% in 2006 to 46% in
2010). Tsao et al18 investigated the trend in vancomycin
susceptibility and correlation with molecular characteris-
tics of MRSA causing severe infections in Taiwan; there was
no vancomycin creep among MRSA isolates, and the
declining trend of vancomycin MIC against MRSA was
ascribed to the increasing prevalence of CA-MRSA over
time. Chen et al19 published their study about susceptibil-
ities of MRSA in vitro to nine antimicrobial agents in
Taiwan; a total of 1725 isolates were acquired from 20
hospitals throughout Taiwan from 2006 to 2010. MIC creep
was found only for daptomycin during this period, but not
for vancomycin, teicoplanin, linezolid, or tigecycline.
In America and Canada, some similar results have been
revealed already. Goldman et al20 found that in the adult
population, the trend during 2000e2005 toward increasing
vancomycin MIC values for S. aureus, which is called MIC
creep, had resulted in the concern that vancomycin may no
longer be suitable to treat invasive staphylococcal infection
in adults where the MIC is  2 mg/mL; however, a significant
vancomycin MIC creep in pediatric populations was not
manifested from 2006 to 2009. Adam et al21 also noted that
there had been no evidence of vancomycin MIC creep in 475
Canadian strains of MRSA isolates obtained from 1995 to
2006 in the adult population.
In our institution, the phenomenon of vancomycin MIC
creep in MRSA exists not only in adults, but also children.
Yeh et al22 reported that the geometric mean of the van-
comycin MIC for MRSA isolates obtained in 2009 was
1.39  0.30 mg/mL, which was significantly higher than the
mean vancomycin MIC obtained in 2001 (1.19  0.34 mg/
mL, p < 0.01) and 2005 (1.99  0.25 mg/mL, p < 0.001). In
our study, the percentile of vancomycin MIC 1.5 mg/mL is
62.5% of the clinical CA-MRSA strains and 28.3% of the
colonizing CA-MRSA isolates. The clinical strains contributen of vancomycin minimum inhibitory concentration creep among
tric patients and healthy children in Northern Taiwan, Journal of
1016/j.jmii.2015.05.013
Figure 1. Genetic relatedness among clinical methicillin-resistant Staphylococcus aureus isolates with vancomycin minimum
inhibitory concentration  1.5 mg/mL. Unweighted pair group method with arithmetic mean dendrogram revealing genetic
relatedness among clinical methicillin-resistant Staphylococcus aureus isolates as determined by pulse-field gel electropho-
resis with smaI. The broken line corresponds to the cutoff level (80%) used to define related pulse-field gel electrophoresis
clones.
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Figure 2. Genetic relatedness among colonizing methicillin-resistant Staphylococcus aureus isolates with vancomycin minimum
inhibitory concentration  1.5 mg/mL. Unweighted pair group method with arithmetic mean dendrogram revealing genetic
relatedness among colonizing methicillin-resistant Staphylococcus aureus isolates as determined by pulse-field gel electrophoresis
with smaI. The broken line corresponds to the cutoff level (80%) used to define related pulse-field gel electrophoresis clones.
Figure 3. The distribution and trend of vancomycin MICs of
methicillin-resistant Staphylococcus aureus clinical isolates
between 2008e2012.
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prescription of vancomycin in patients with MRSA infection
over the past few decades. As a result, the decreased
vancomycin susceptibility among clinical MRSA isolates has
become increasingly common. Although the vancomycin
MIC creep percentile of the colonizing CA-MRSA is lower
than that of the clinical one, the possibility of MRSA
infection due to colonization still exists.
Yeh et al22 suggested that vancomycin should be pre-
scribed to treat MRSA infections if the vancomycin MIC
is < 2 mg/mL, while alternative treatments should bePlease cite this article in press as: Chang C-N, et al., An investigatio
methicillin-resistant Staphylococcus aureus strains isolated from pedia
Microbiology, Immunology and Infection (2015), http://dx.doi.org/10.considered if a clinical or microbiologic response to van-
comycin fails. In the present study, we found that 69% of
clinical MRSA isolates had vancomycin creep; a high dose
of vancomycin (60 mg/kg/d) is recommended for patients
infected MRSA with vancomycin MIC creep.8 All of the
MRSA strains were susceptible to daptomycin; thus dap-
tomycin should be considered when vancomycin treatment
fails or a poor response occurs or when a reasonable
trough level could not be achieved.
In the present study we found that among the CA-MRSA
strains, the clinical isolates contained 59.8% SCCmec type
VT and 23% SCCmec type IV; the colonizing isolates included
85.8% SCCmec type IV and 14.2% SCCmec type VT. The
phenomenon of vancomycin MIC creep actually exists in the
colonized strains, which means that healthy children with
colonized MRSA isolates have higher possibility to develop
invasive disease caused by MRSA. Furthermore, the per-
centage of MRSA isolates with vancomycin MIC 1.5 mg/mL
was always > 50% during the study period of 2008e2012;
the fluctuated curve revealed no declining or rising trend of
vancomycin MIC creep but the creeping phenomenon really
subsisted. Nevertheless, there were dissimilar molecular
characteristics among the colonizing MRSA isolates and
clinical strains. The results were similar to previous reports
from Taiwan.2,11,16 The risk of these strains spreading and
leading to infection requires further evaluation.
Rodrı´guez et al23 found that colonizing MRSA with similar
molecular characteristics of those causing infectionn of vancomycin minimum inhibitory concentration creep among
tric patients and healthy children in Northern Taiwan, Journal of
1016/j.jmii.2015.05.013
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risk of infection among the child population. The partici-
pants of the study were children from a university hospital
and day care centers. Javidnia et al24 confirmed the pres-
ence of at least one clonal group of MRSA strains in each of
the three hospitals investigated; through exact typing, the
strains were shown to be found in the surroundings of the
same hospital and had highly similar antibiotic resistance
patterns to those isolated from patients. Colonizing MRSA
with similar molecular characteristics to infectious strains
displays the importance for public health of monitoring
these populations owing to the risks of the strains dissem-
inating and causing infection.
There was a large variety in PFGE types of MRSA with
vancomycin MIC 1.5 mg/mL. No evidence of clonal
dissemination of MRSA strains in this tertiary hospital was
found. Great diversity of PFGE types existed in both clinical
and colonizing MRSA isolates; there was no evidence or
association between the clinical and colonizing MRSA iso-
lates with vancomycin MIC creep. This phenomenon is
meaningful for infection control both in the community and
in the hospital.
The study has several limitations. First, this is a retro-
spective study for the pediatric population at a single
medical center, perhaps providing a selection bias and the
number of isolates is limited locally in Northern Taiwan.
Second, MICs were only analyzed over a 5-year period;
longer periods are needed to an expansive investigation of
MIC change. Third, we obtained vancomycin MICs using the
Etest method rather than the broth microdilution method;
the two systems have been reported to yield MIC values
differing by up to two-fold.25
In conclusion, we detected the existence of vancomycin
MIC creep in our hospital and the community during the
study period. The increase in vancomycin MICs has been
associated with worse outcomes in children with invasive
MRSA disease. Furthermore, using molecular analysis by
PFGE and SCCmec typing MRSA in two different pediatric
populations from the hospital and the community, we found
great diversity in both strain populations. There was no as-
sociation between the clinical and colonizing MRSA isolates
with vancomycin MIC creep, which means that there was no
mutual relationship between the MRSA isolates obtained
from the hospital and the community. The dissimilarity in
epidemiological characteristics between the two populations
provides the basis for the design of control and prevention
strategies for colonizing and infectious MRSA isolates.23
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